Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer death among women in the United States. Recent extensive integrated genomic analysis of high-grade serous ovarian adenocarcinomas has provided important insights about the repertoire of molecular aberrations characteristic for this, the most common and deadly, form of EOC. However, interpretation of the discovered aberrations is complicated because the cell of origin of this disease has not yet been unequivocally defined. Recently, we have identified the hilum region of the mouse ovary, the transitional/junction area between the ovarian surface epithelium (OSE), mesothelium and tubal (Fallopian or oviductal) epithelium as a previously unrecognized stem cell niche of the OSE. As we have shown, these cells express stem cell markers and display long-term stem cell properties ex vivo and in vivo, according to serial sphere generation and to long-term lineage tracing assays, respectively. Importantly, the hilar cells exhibit increased transformation potential after inactivation of tumor suppressor genes p53 (Trp53) and Rb (Rb1), pathways that are frequently altered in high grade serous adenocarcinoma. Our preliminary results indicate existence of stem cell niche in the mouse tubal epithelium, with a particular accumulation of cells in the most distal part of the uterine tue, near the tubal epithelium/mesothelium junction area. Notably both OSE and TE stem cell niches are characterized by high activity of the miR-34/MET network. Since OSE and tubal epithelium have a common origin from the coelomic epithelium both in mice and humans, we hypothesize that ovarian carcinomas arise from several developmentally connected stem cell niches within OSE/mesothelium/TE junction areas, where stem cells are more prone to transformation because of the innately active miR-34/MET network. To address this hypothesis we propose to (1) characterize a putative stem cell niche in the TE and establish its role in EOC formation, (2) perform comparative molecular characterization of OSE-SC and TE-SC niches, and (3) identify and characterize stem cell niches in human OSE and TE. It is expected that our work will provide critical missing links between clinical and experimental studies of ovarian carcinoma origin. Importantly, it should lead to identification of new diagnostic and prognostic markers and therapeutic targets.

Public Health Relevance

Ovarian cancer can be successfully treated if diagnosed at an early stage, with 90% of patients with 5-year survival. However, due to undetected progression of EOC, nearly 70% of women are diagnosed at advanced, commonly incurable stages. Identification and characterization of the OSE/tubal epithelium/mesothelium junction areas as a cancer prone-stem cell niches may lead to a paradigm shift in our understanding of ovarian carcinoma pathogenesis and stimulate targeted search for preneoplastic/early neoplastic lesions in such locations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA182413-02
Application #
9069746
Study Section
Molecular Oncogenesis Study Section (MONC)
Program Officer
Sathyamoorthy, Neeraja
Project Start
2015-05-18
Project End
2020-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Cornell University
Department
Other Basic Sciences
Type
Schools of Veterinary Medicine
DUNS #
872612445
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Sundberg, John P; Boyd, Kelli; Hogenesch, Harm et al. (2018) Training mouse pathologists: 16th annual workshop on the pathology of mouse models of human disease. Lab Anim (NY) 47:38-40
Fu, Dah-Jiun; Miller, Andrew D; Southard, Teresa L et al. (2018) Stem Cell Pathology. Annu Rev Pathol 13:71-92
Sundberg, John P; Boyd, Kelli; Hogenesch, Harm et al. (2017) Training mouse pathologists: 15 years of workshops on the pathology of mouse models of human disease. Lab Anim (NY) 46:204-206
Schmoeckel, Elisa; Odai-Afotey, Ashley A; Schleißheimer, Michael et al. (2017) LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions. Mod Pathol 30:1241-1250
Lu, Yen-Chun; Fu, Dah-Jiun; An, Duo et al. (2017) Scalable Production and Cryostorage of Organoids Using Core-Shell Decoupled Hydrogel Capsules. Adv Biosyst 1:
Flesken-Nikitin, Andrea; Harlan, Blaine A; Nikitin, Alexander Yu (2016) Transplantation Into the Mouse Ovarian Fat Pad. J Vis Exp :
Harlan, Blaine A; Nikitin, Alexander Yu (2015) A Quest for Better Mouse Models of Breast and Ovarian Cancers. EBioMedicine 2:1268-9
Sundberg, John P; Hogenesch, Harm; Nikitin, Alexander Yu et al. (2012) Training mouse pathologists: ten years of workshops on the Pathology of Mouse Models of Human Disease. Toxicol Pathol 40:823-5